EFFECT OF STRATIFIED DOSE OF NOREPINEPHRINE ON CELLULAR IMMUNE RESPONSE IN PATIENTS WITH SEPTIC SHOCK AND THE CONSTRUCTION OF A PROGNOSTIC RISK MODEL

被引:0
|
作者
Wang, Qiang [1 ]
Tang, Jiefu [1 ]
Li, Yao [2 ]
Lu, Jiafei [1 ]
Yang, Dexing [3 ]
He, Chen [1 ]
Li, Ting [1 ]
Fu, Kai [1 ]
Liu, Rong [1 ,4 ]
机构
[1] Kunming Med Univ, Affiliated Hosp 1, Yunnan Geriatr Med Ctr, Dept Geriatr Intens Care Med, Kunming, Peoples R China
[2] First Peoples Hosp Yunnan Prov, Stomatol Res Ctr, Kunming, Peoples R China
[3] Yunnan First Peoples Hosp, Dept Emergency Med, Kunming, Peoples R China
[4] 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China
来源
SHOCK | 2024年 / 62卷 / 01期
关键词
Norepinephrine; septic shock; prognostic risk model; cellular immune response; stratified dose; SEPSIS; IMMUNOSUPPRESSION; DEFINITIONS;
D O I
10.1097/SHK.0000000000002363
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To explore the effect of a stratified dose of norepinephrine (NE) on cellular immune response in patients with septic shock, and to construct a prognostic model of septic shock. Methods: A total of 160 patients with septic shock (B group) and 58 patients with sepsis (A group) were given standard cluster therapy. Patients with septic shock were divided into four groups (B1-B4 groups: 0.01-0.2, 0.2-0.5, 0.5-1.0, and >1 mu g/kg/min) according to the quartile method of the early (72 h) time-weighted average dose of NE and clinical application. The cellular immune indexes at 24 h (T0) and 4-7 days (T1) after admission were collected. The difference method was used to explore the effect of NE stratified dose on cellular immune effect in patients with septic shock. A multivariate COX proportional risk regression model was used to analyze the independent prognostic risk factors, and a prognostic risk model was constructed. Results: The differences of Delta IL-1 beta, Delta IL-6, Delta IL-10, absolute value difference of T lymphocyte (Delta CD3+/CD45+#) and Th helper T cell (Delta CD3+ CD4+/CD45+#), CD64 infection index difference, Delta mHLA-DR, regulatory T lymphocyte ratio difference (Delta Tregs%) between group A, B1, B2, B3, and B4 were statistically significant (P < 0.05). There was a nonlinear relation between the stratified dose of NE and Delta IL-6, Delta IL-10, Delta CD3+/CD45+#, Delta mHLA-DR%. The threshold periods of NE-induced proinflammatory and anti-inflammatory immune changes were 0.3-0.5 mu g/kg/min. Multivariate COX model regression analysis showed that age, nutritional patterns, weighted average dose of norepinephrine, IL-6, absolute value of T lymphocytes, and mHLA-DR were independent risk factors affecting the prognosis of patients with septic shock (P < 0.05). The prognostic risk model was constructed (AUC value = 0.813, 95% CI: 0.752-0.901). Conclusion: NE has a certain inhibitory effect on cellular immune function in patients with septic shock. A prognostic risk model was constructed with stronger prediction efficiency for the prognosis of patients with septic shock.
引用
收藏
页码:32 / 43
页数:12
相关论文
共 50 条
  • [1] Effect of norepinephrine dosage on mortality in patients with septic shock
    Yamamura, Hitoshi
    Kawazoe, Yu
    Miyamoto, Kyohei
    Yamamoto, Tomonori
    Ohta, Yoshinori
    Morimoto, Takeshi
    JOURNAL OF INTENSIVE CARE, 2018, 6
  • [2] Effect on capillary refill time of volume expansion and increase of the norepinephrine dose in patients with septic shock
    Fage, Nicolas
    Moretto, Francesca
    Rosalba, Daniela
    Shi, Rui
    Lai, Christopher
    Teboul, Jean-Louis
    Monnet, Xavier
    CRITICAL CARE, 2023, 27 (01)
  • [3] The impact of norepinephrine dose reporting heterogeneity on mortality prediction in septic shock patients
    Morales, Sebastian
    Wendel-Garcia, Pedro D.
    Ibarra-Estrada, Miguel
    Jung, Christian
    Castro, Ricardo
    Retamal, Jaime
    Cortinez, Luis I.
    Severino, Nicolas
    Kiavialaitis, Greta Emilia
    Ospina-Tascon, Gustavo
    Bakker, Jan
    Hernandez, Glenn
    Kattan, Eduardo
    CRITICAL CARE, 2024, 28 (01)
  • [4] Optimal norepinephrine-equivalent dose to initiate epinephrine in patients with septic shock
    Ammar, Mahmoud A.
    Limberg, Emily C.
    Lam, Simon W.
    Ammar, Abdalla A.
    Sacha, Gretchen L.
    Reddy, Anita J.
    Bauer, Seth R.
    JOURNAL OF CRITICAL CARE, 2019, 53 : 69 - 74
  • [5] Effect of norepinephrine dosage on mortality in patients with septic shock
    Hitoshi Yamamura
    Yu Kawazoe
    Kyohei Miyamoto
    Tomonori Yamamoto
    Yoshinori Ohta
    Takeshi Morimoto
    Journal of Intensive Care, 6
  • [6] Effect on capillary refill time of volume expansion and increase of the norepinephrine dose in patients with septic shock
    Nicolas Fage
    Francesca Moretto
    Daniela Rosalba
    Rui Shi
    Christopher Lai
    Jean-Louis Teboul
    Xavier Monnet
    Critical Care, 27
  • [7] Glibenclamide dose response in patients with septic shock: Effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport
    Morelli, Andrea
    Lange, Matthias
    Ertmer, Christian
    Broeking, Katrin
    Van Aken, Hugo
    Orecchioni, Alessandra
    Rocco, Monica
    Bachetoni, Alessandra
    Traber, Daniel L.
    Landoni, Giovanni
    Pietropaoli, Paolo
    Westphal, Martin
    SHOCK, 2007, 28 (05): : 530 - 535
  • [8] Effect of timing of norepinephrine administration on prognosis of patients with septic shock: A prospective cohort study
    Li, Yuting
    Zhang, Deyou
    Li, Hongxiang
    Wang, Youquan
    Zhang, Dong
    JOURNAL OF INTENSIVE MEDICINE, 2025, 5 (02): : 160 - 166
  • [9] The Effect of Propofol and Dexmedetomidine Sedation on Norepinephrine Requirements in Septic Shock Patients: A Crossover Trial
    Morelli, Andrea
    Sanfilippo, Filippo
    Arnemann, Philip
    Hessler, Michael
    Kampmeier, Tim G.
    D'Egidio, Annalia
    Orecchioni, Alessandra
    Santonocito, Cristina
    Frati, Giacomo
    Greco, Ernesto
    Westphal, Martin
    Rehberg, Sebastian W.
    Ertmer, Christian
    CRITICAL CARE MEDICINE, 2019, 47 (02) : E89 - E95
  • [10] Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock
    Hodge, Emily K.
    Hughes, Darrel W.
    Attridge, Rebecca L.
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (10) : 816 - 823